1. Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy. Issue 11 (29th June 2013) Authors: Tong, W.H.; Pieters, R.; Hop, W.C.J.; van der Sluis, I.M. Journal: Pediatric blood & cancer Issue: Volume 60:Issue 11(2013:Nov.) Page Start: 1914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol. (January 2022) Authors: Stutterheim, J.; de Lorenzo, P.; van der Sluis, I.M.; Alten, J.; Ancliffe, P.; Attarbaschi, A.; Aversa, L.; Boer, J.M.; Biondi, A.; Brethon, B.; Diaz, P.; Cazzaniga, G.; Escherich, G.; Ferster, A.; Kotecha, R.S.; Lausen, B.; Leung, Alex WK.; Locatelli, F.; Silverman, L.; Stary, J. Journal: European journal of cancer Issue: Volume 160(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗